Sartorius Stedim Biotech annual r&d spending
2020
2021
2022
2023
2024
2025
Sartorius Stedim Biotech R&D Spending Growth & History (DIM)
Sartorius Stedim Biotech's r&d spending was €133.1M for fiscal 2025.
View full Sartorius Stedim Biotech company overviewSartorius Stedim Biotech annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €133.1M | −€11.0M | −7.63% |
| 2024 | 2024-12-31 | €144.1M | €14.6M | +11.27% |
| 2023 | 2023-12-31 | €129.5M | −€2.9M | −2.19% |
| 2022 | 2022-12-31 | €132.4M | €21.9M | +19.82% |
| 2021 | 2021-12-31 | €110.5M | €26.0M | +30.85% |
| 2020 | 2020-12-31 | €84.5M | — | — |
Sartorius Stedim Biotech quarterly r&d spending
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €35.3M | €3.2M | +9.97% |
| Q1 2026 | 2026-03-31 | €38.4M | −€800,000 | −2.04% |
| Q4 2025 | 2025-12-31 | €31.7M | — | — |
| Q2 2025 | 2025-06-30 | €32.1M | — | — |
| Q1 2025 | 2025-03-31 | €39.2M | — | — |
Sartorius Stedim Biotech r&d spending trends
Over the last five fiscal years, Sartorius Stedim Biotech's r&d spending increased from €84.5M to €133.1M, a change of €48.6M. The latest reported quarter, Q2 2026, shows €35.3M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
reported R&D expense
TickerStat standardizes research and development expense reported in company official filings, including the software-specific standardized R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sartorius Stedim Biotech source filings ↗